Techno Medica Co., Ltd. (TYO:6678)

Techno Medica Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	8,679	8,976	9,061	8,586	11,750	11,523
Cash & Short-Term Investments	8,679	8,976	9,061	8,586	11,750	11,523
Cash Growth	0.11%	-0.94%	5.53%	-26.93%	1.97%	13.66%
Accounts Receivable	2,933	4,382	3,904	4,297	3,574	3,652
Other Receivables	-	-	48	-	83	-
Receivables	2,933	4,382	3,952	4,297	3,657	3,652
Inventory	2,326	2,282	2,607	2,154	1,865	1,229
Prepaid Expenses	41	41	49	36	28	36
Other Current Assets	9	15	9	8	7	32
Total Current Assets	13,988	15,696	15,678	15,081	17,307	16,472
Property, Plant & Equipment	1,331	1,347	1,404	1,448	1,527	1,492
Long-Term Investments	289	313	331	410	210	146
Other Intangible Assets	43	47	59	71	22	33
Long-Term Deferred Tax Assets	587	563	465	422	375	363
Other Long-Term Assets	1	-	1	1	2	2
Total Assets	16,239	17,966	17,938	17,433	19,443	18,508

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	697	1,299	1,576	1,416	1,499	1,282
Accrued Expenses	405	315	305	294	273	259
Current Income Taxes Payable	235	740	378	778	413	665
Current Unearned Revenue	121	98	107	96	98	114
Other Current Liabilities	787	631	909	775	527	310
Total Current Liabilities	2,245	3,083	3,275	3,359	2,810	2,630
Pension & Post-Retirement Benefits	249	245	239	220	210	192
Other Long-Term Liabilities	36	228	35	36	37	36
Total Liabilities	2,530	3,556	3,549	3,615	3,057	2,858

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	1,069	1,069	1,069	1,069	1,069	1,069
Additional Paid-In Capital	985	985	996	1,002	967	967
Retained Earnings	16,163	16,864	16,265	15,730	14,890	14,260
Treasury Stock	-4,510	-4,510	-3,941	-3,984	-541	-648
Comprehensive Income & Other	2	2	-	1	1	2
Shareholders' Equity	13,709	14,410	14,389	13,818	16,386	15,650
Total Liabilities & Equity	16,239	17,966	17,938	17,433	19,443	18,508

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash (Debt)	8,679	8,976	9,061	8,586	11,750	11,523
Net Cash Growth	0.11%	-0.94%	5.53%	-26.93%	1.97%	13.66%
Net Cash Per Share	1270.48	1301.42	1308.54	1101.49	1392.21	1356.54
Filing Date Shares Outstanding	6.66	6.79	6.93	6.95	8.47	8.43
Total Common Shares Outstanding	6.66	6.79	6.93	6.95	8.47	8.43
Working Capital	11,743	12,613	12,403	11,722	14,497	13,842
Book Value Per Share	2057.51	2123.72	2076.70	1987.84	1933.92	1855.48
Tangible Book Value	13,666	14,363	14,330	13,747	16,364	15,617
Tangible Book Value Per Share	2051.06	2116.79	2068.19	1977.62	1931.33	1851.57

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error